MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions
View by Date

Monday, October 8, 2018

1:15pm-2:45pm
Alterations of cortical metabotropic glutamate receptor-mediated signaling in patients with Parkinson’s disease

JY. Lee, YK. Kim, SA. Shin, SH. Seo, JS. Lee, YS. Lee, JM. Jeong, B. Jeon (Seoul, Republic of Korea)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Hall 3FG
1:15pm-2:45pm
Altered amplitude of low-frequency fluctuations and functional connectivity in excessive daytime sleepiness in Parkinson disease

X. Wang, K. Zhang (Nanjing, China)

Parkinson's Disease: Non-Motor Symptoms  ·  Hall 3FG
1:15pm-2:45pm
Altered connectivity in ventral and dorsal attentional networks in patients with Parkinson’s disease: Association with freezing of gait

I. Maidan, Y. Jacob, N. Giladi, J. Hausdorff, A. Mirelman (Tel Aviv, Israel)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Hall 3FG
1:15pm-2:45pm
Altered putamen and cerebellum connectivity between different subtypes of Parkinson’s disease

B. Shen, L. Zhang (Nanjing, China)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Hall 3FG
1:15pm-2:45pm
Alzheimer’s Disease Genetic Risk Variants Predict Cognitive Decline in Parkinson’s Disease

T. Tropea, K. Maddy, J. Rick, J. Trojanowkski, D. Weintraub, A. Chen-Plotkin (Philadelphia, PA, USA)

Parkinson's Disease: Cognition  ·  Hall 3FG
1:15pm-2:45pm
Amyloid deposition affects cognitive manifestations in Parkinson’s disease: The PPMI dataset

E. Fiorenzato, R. Biundo, D. Cecchin, AC. Frigo, L. Weis, J. Kim, A. Strafella, A. Antonini (Venice, Italy)

Parkinson's Disease: Cognition  ·  Hall 3FG
1:15pm-2:45pm
Amyloid PET and cognition in Parkinson’s disease

T. Melzer, M. Stark, D. Myall, R. Keenan, L. Livingston, M. Almuqbel, M. MacAskill, T. Pitcher, K. Horne, S. Grenfell, M. Pascoe, B. Young, J. Wang, S. Marsh, D. Miller, J. Dalrymple-Alford, T. Anderson (Christchurch, New Zealand)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Hall 3FG
1:15pm-2:45pm
An analysis of cortical thickness in early Parkinson’s disease patients with cognitive impairment

M. Mei, K. Nie, Y. Gao, Y. Zhang, L. Wang (Guangzhou, China)

Parkinson's Disease: Cognition  ·  Hall 3FG
1:15pm-2:45pm
An investigation of the relationship between computational neuropsychological testing outcomes and symptoms of Parkinson’s disease

L. Jiang, Y. Zhu, Z. Ye, Z. Pei, L. Chen (Guangzhou, China)

Parkinson's Disease: Cognition  ·  Hall 3FG
1:15pm-2:45pm
Analysis of gene polymorphisms of Parkinson’s disease in Han Chinese population

H. Jin, J. Zhang, K. Li, C. G, C. Liu (Suzhou, China)

Parkinson's Disease: Genetics  ·  Hall 3FG
  • «Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 59
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
        • Help & Support
        • About Us
        • Cookies & Privacy
        • Wiley Job Network
        • Terms & Conditions
        • Advertisers & Agents
        Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
        Wiley